Antibody Therapy Market

The antibody therapy systems market is reported to reach a valuation of USD 144,734.5 million in 2025 to USD 301,088.9 million by 2035. In 2025, monoclonal antibodies dominate the antibody therapy market and holds major market share of 78.3% in 2025 due to their efficacy and broad clinical use. Hospitals lead as key end users, accounting for 62.6% of sales in 2025, driven by the need for intravenous delivery, patient monitoring, and specialized care, which are best managed in hospital settings.